venBio Global Strategic Fund II L.P. 13D and 13G filings for Checkmate Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-06-07 4:15 pm Sale |
2022-05-31 | 13G | Checkmate Pharmaceuticals, Inc. CMPI |
venBio Global Strategic Fund II L.P. | 0 0.000% |
-2,535,158 (Position Closed) |
Filing |
| 2022-05-05 4:15 pm Sale |
2022-05-03 | 13G | Checkmate Pharmaceuticals, Inc. CMPI |
venBio Global Strategic Fund II L.P. | 2,535,158 11.500% |
-1,138,216 (-30.99%) |
Filing |
| 2020-10-06 3:19 pm Purchase |
2020-08-11 | 13G | Checkmate Pharmaceuticals, Inc. CMPI |
venBio Global Strategic Fund II L.P. | 3,673,374 17.100% |
3,673,374 (New Position) |
Filing |